You can access the annual and quarterly cash flow statements of Strata Critical Medical Ord Shs Class A to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---37.30M
Net income from continuing operations
--57.42M
Operating gains losses
--1.70M
Deferred tax
--554.00K
Other non-cash items
---51.37M
Change in working capital
--7.99M
-Change in receivables
---1.77M
-Change in prepaid expenses
--2.43M
-Change in payables and accrued expense
--7.48M
-Change in other current assets
--592.00K
-Change in other current liabilities
---709.00K
Cash from non-recurring investing activities
Cash from operating activities
---37.30M
Investing cash flow
Net cash from continuing investing activities
--3.19M
Capital expenditures
--3.19M
Net cash flow from disposal of fixed assets
--2.90M
Net cash flow from intangible asset transactions
--297.00K
Net cash flow from business transactions
---66.42M
Net cash flow from investment products
--72.01M
Cash from non-current investing activities
Net cash flow from investing activities
--2.40M
Financing cash flow
Cash flow from continuous financing activities
---1.79M
Net cash flow from common stock issuance/repurchase
--65.00K
Net cash flow from other financing activities
---1.85M
Net cash from non-recurrent financing activities
Net cash from financing activities
---1.79M
Net cash flow
Beginning cash balance
--60.32M
Current period cash flow changes
---37.30M
Effect of exchange rate changes
---616.00K
Ending cash balance
--23.02M
Free cash flow
---40.49M
Currency unit
USD
Audit opinions
--
FAQs
What is the cash flow statement?
This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.